Solicited report from the USA by a physician of a female with an event of non-serious RETURN OF SYMPTOMS 
OF JOINT PAINT with HUMIRA (ADALIMUMAB).
In July 2015, the patient experienced RETURN OF SYMPTOMS OF JOINT PAINT.  The patient experienced a 
return of her symptoms of joint paint. She increased her HUMIRA dose. She took MULTIVITAMIN as concomitant 
drug.
Causality for HUMIRA(ADALIMUMAB)
The reporter's statement of causality for the event of RETURN OF SYMPTOMS OF JOINT PAINT was not 
Print Time: 15-JUL-2016 02:35 PM If a field is blank, there is no data for that field Page 295 of 517
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information
provided.